News | April 20, 2026
Rusan Pharma secures Japan PMDA GMP approval for API, FDF facilities
PMDA is regarded among the most stringent regulatory bodies globally
PMDA is regarded among the most stringent regulatory bodies globally
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
The company allocated €56 million to research and development for next-generation line solutions
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping
Subscribe To Our Newsletter & Stay Updated
